Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
Jennifer K. Bender(Robert Koch Institute), Guido Werner(Robert Koch Institute), Henrik Westh(Hvidovre Hospital), Kirsten Schaffer(St. Vincent's University Hospital), Ana R. Freitas(Universidade do Porto), Annalisa Pantosti(Istituto Superiore di Sanità), Ewa Sadowy(Medical University of Warsaw), Teresa M. Coque(Instituto Cajal), Anette M. Hammerum(Statens Serum Institut), Carla Novais(Fernando Pessoa University), Luísa Maria Sobreira Vieira Peixe(Universidade do Porto), Kristin Hegstad(University Hospital of North Norway), S. Murchan(Health Protection Surveillance Centre), Karen Burns(Royal College of Surgeons in Ireland), María Del Grosso(Istituto Superiore di Sanità), Vincent Cattoir(Inserm)
Cited by 283
Related Papers
Defining and combating antibiotic resistance from One Health and Global Health perspectives
|Nature Microbiology|2019|1.2k
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
What is a resistance gene? Ranking risk in resistomes
|Nature Reviews Microbiology|2014|1k
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817